logowsbdaily | Tue, 20 Dec 2022 03:11:23 EST Where you find Tomorrow’s Hot Stocks Yesterday! 

NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.

Amyris, Inc.
(AMRS)

Amyris, Inc.
5885 Hollis Street
Suite 100
EmeryVille, CA 94608
United States
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, O... Read More

Summary & Charts

Price$ 1.98+0.32 (+19.27%)
Day's Range$ 1.64 - 2.00 
Previous Close$ 1.66
Market Cap$ 573.02M USD
Short Interest %N/A
FloatN/A
OutstandingN/A
ExchangeNasdaqGS
IndustrySpecialty Chemicals
SectorBasic Materials
Volume7.82M
Avg. Volume (20 day)4.95M
Rel. Volume (20 day)1.58
Rel. Volume (3 month)1.39
RatingBNeutral
DCFN/AStrong Buy
Debt/Equity-274.23 %Sell
ROE229.96 %Strong Buy
ROA-48.74 %Sell
P/E-5.12 %Sell
P/B-1.51 %Strong Sell
DateOpenHighLowCloseChangeVolumeR. Vol. (20d)R. Vol. (3m)Mentions
Dec 16, 2022$ 1.69$ 2.00$ 1.64$ 1.98+0.327,815,8951.581.392
Dec 15, 2022$ 1.70$ 1.76$ 1.64$ 1.66-0.103,604,4980.750.611
Dec 14, 2022$ 1.64$ 1.81$ 1.63$ 1.76+0.115,424,9061.120.88
Dec 13, 2022$ 1.73$ 1.77$ 1.57$ 1.65+0.056,306,7761.241.01
Dec 12, 2022$ 1.67$ 1.69$ 1.53$ 1.606,327,3991.211.01
Dec 09, 2022$ 1.74$ 1.78$ 1.59$ 1.60-0.144,856,5450.880.78
Dec 08, 2022$ 1.70$ 1.82$ 1.66$ 1.74+0.062,815,7470.460.46
Dec 07, 2022$ 1.78$ 1.83$ 1.65$ 1.68-0.113,105,8670.400.501
Dec 06, 2022$ 1.87$ 1.87$ 1.77$ 1.79-0.042,771,1810.350.44
Dec 05, 2022$ 1.78$ 1.94$ 1.72$ 1.83+0.056,168,8700.780.97
Dec 02, 2022$ 1.78$ 1.86$ 1.69$ 1.78-0.025,090,9740.660.80
Dec 01, 2022$ 1.75$ 1.87$ 1.72$ 1.80+0.075,452,0690.720.85
Nov 30, 2022$ 1.65$ 1.74$ 1.52$ 1.73+0.139,526,0881.271.47
Nov 29, 2022$ 1.74$ 1.75$ 1.57$ 1.60-0.118,391,5651.161.30
Nov 28, 2022$ 1.85$ 1.85$ 1.70$ 1.71-0.136,863,8240.961.07
Nov 25, 2022$ 1.93$ 1.94$ 1.84$ 1.84-0.102,354,3970.330.37
Nov 23, 2022$ 1.98$ 2.05$ 1.91$ 1.94+0.013,725,6420.510.58
Nov 22, 2022$ 2.11$ 2.11$ 1.90$ 1.93-0.143,536,9520.480.54
Nov 21, 2022$ 2.18$ 2.19$ 2.06$ 2.07-0.152,472,3700.340.38
Nov 18, 2022$ 2.18$ 2.23$ 2.12$ 2.22+0.102,469,2430.340.37

News

The latest news about Amyris, Inc. (AMRS).

PennyStocks | 2022-12-16 14:17:38
Penny stocks to buy according to analysts. Are they right?
Seeking Alpha | 2022-12-09 18:22:52
Amyris is on the cusp of closing a record strategic transaction slated to generate ~$500mm in cash value. All indications point to a transaction closing in the next two to three weeks.
PennyStocks | 2022-11-18 14:15:55
Penny stocks to watch with unusual options activity this week. The post 7 Top Penny Stocks With Unusual Options Activity, Time To Buy?
The Motley Fool | 2022-11-09 17:58:00
To say that the company had a third quarter to forget is quite the understatement.
Zacks Investment Research | 2022-11-08 19:33:34
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -109.52% and 36.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Seeking Alpha | 2022-11-08 19:08:08
Amyris, Inc. (NASDAQ:AMRS ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Han Kieftenbeld - Chief Financial Officer John Melo - President & Chief Executive Officer Eduardo Alvarez - Chief Operating Officer Conference Call Participants Colin Rusch - Oppenheimer Rachel Vatnsdal - JPMorgan Korinne Wolfmeyer - Piper Sandler Steven Mah - Cowen and Company Dan Rizzo - Jefferies Rick Schottenfeld - Schottenfeld Opportunities Fund Graham Tanaka - Tanaka Capital Management Operator Welcome to the Amyris' Third Quarter 2022 Financial Results Conference Call. This call is being webcast live on the Events page of the Investors section of the Amyris website at amyris.com.
Seeking Alpha | 2022-11-07 13:01:12
"Fit To Win," high ROI Capex and innovative marketing are reducing cash burn equaling 19% of H2 2022 and 26% of 2023 product sales, delivering positive cash flow in 2023. Barra Bonita changes everything.  Mfg. efficiencies and 30-60% lower COGS swings Amyris Ingredients margins from negative to positive 20-50%, producing faster and more profitable Ingredient growth than we expected.

Earnings

DateTimeEPS ExpectedEPS Reported%Revenue ExpectedRevenue Reported%
2022-11-08BMO-0.21-0.44109.52%------
2022-08-09BMO-0.26-0.3430.76%------
2022-05-10BMO-0.3-0.3723.33%44M58M30.43%
2022-03-01BMO-0.20.12160%------
2021-11-08BMO-0.15-0.1126.67%81M48M-40.61%
2021-08-05BMO-0.13-0.1623.07%53M52M-1.26%
2021-05-06BMO-0.02-1.085300%73M177M141.08%
2021-03-02BMO-0.09-0.44388.88%69M80M14.83%

Top Discussions

These are the top discussions over the last 24-hours that mention the AMRS stock ticker symbol.


Failures to Deliver

Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.

Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.

Last Updated: Tue, 14 Dec 2021 12:00 EST


Support & Feedback

Got feedback or suggestions for more awesomeness? Or wanna keep up to date with changes?

@wsbdaily@wsbdailywsbdaily subredditwsbdaily

No obligation, if you'd like to support us with development and hosting costs then

Buy Me A Coffee

Disclaimer

WE ARE NOT AFFILIATED WITH REDDIT, THE LEADERSHIP OR MODERATOR TEAMS OF ANY OF THE SUBREDDITS WE CRAWL NOR WITH ANY OTHER WEBSITE, COMPANY OR DATA PROVIDER FROM WHICH WE PULL AND/OR AGGREGATE DATA FROM.

ALL CONTENT ON THIS SITE IS SOLEY FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY. THE SITE AND CONTENT, ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. ANY CONTENT OR STATEMENT HEREIN SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, OR AS AN OFFER TO BUY, SELL, OR SOLICIT THE PURCHASE OR SALE OF ANY SECURITY OR FINANCIAL INSTRUMENT. DO YOUR OWN DUE DILIGENCE.

THE INFORMATION ON THIS SITE IS NOT UPDATED IN REAL-TIME, EACH DATASET SPECIFIES WHEN IT WAS “LAST UPDATED”. MOST INFORMATION IS CURRENTLY INDEPENDENTLY PERIODICALLY UPDATED EVERY 30 TO 150 MINUTES AND ONLY WHEN THE MARKETS ARE CLOSED. YOU BEAR ALL RISKS ASSOCIATED WITH THE USE OF THE SITE AND CONTENT, INCLUDING WITHOUT LIMITATION, ANY RELIANCE ON THE ACCURACY, COMPLETENESS OR USEFULNESS OF ANY CONTENT AVAILABLE ON THE SITE. YOUR USE OF THE INFORMATION CONTAINED HEREIN IS SOLELY AT YOUR OWN RISK. DO YOUR OWN DUE DILIGENCE.

There are high risks associated with investing in securities. Investing in stocks, options, bonds, ETFs, mutual funds, and money market funds involve risk of substantial loss. Loss of principal is possible. Some high risk investments may use leverage, which will greatly accentuate any losses. Foreign investing involves special risks, including a greater volatility and political, economic and currency risks and differences in accounting methods. Any past investment performance is not a guarantee or predictor of future investment performance. DO YOUR OWN DUE DILIGENCE.

The software providing the content on this site is currently in an alpha state. Although care is taken to publish accurate data inaccurate information is very, very possible. Use at your own risk. DO YOUR OWN DUE DILIGENCE.